MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Change in Cash
-$18,481K
Free Cash flow
-$18,481K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Right-of-use assets
Depreciation
Other current assets
Others
Negative Cash Flow Breakdown
Accounts payable and accrued exp...
Net loss
Operating lease liabilities
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-09-30
2025-06-30
Depreciation
-
2,000
Net loss
-3,706
-81,119
Impairment on lab equipment held-for-sale
-
3,000
Depreciation
797
1,991
Impairment on lab equipment held-for-sale
271
2,975
Write-off of prepaid expenses related to program terminations
0
2,549
Share-based compensation expense
109
-608
Amortization of discount on marketable securities
0
97
Receivable from former parent
0
-51
Prepaid expenses
-309
-3,606
Other current assets
-608
-283
Right-of-use assets
-1,227
-2,422
Other assets
0
-10
Accounts payable and accrued expenses
-16,472
2,672
Operating lease liabilities
-1,626
-2,849
Other liabilities
2
-47
Cash flows used in operating activities
-18,481
-68,161
Purchases of marketable securities
0
0
Sales and maturities of marketable securities
0
29,000
Proceeds from sale of property and equipment
0
780
Additions of property and equipment
0
15
Cash flows provided by (used in) investing activities
0
29,765
Proceeds from issuance of ordinary shares under employee share plans
0
28
Cash flows provided by financing activities
0
28
Net decrease in cash, cash equivalents and restricted cash
-18,481
-38,368
Cash and cash equivalents at beginning of period
117,431
-
Cash and cash equivalents at end of period
60,582
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
MURA Cash Flow Sankey Diagram
Sankey diagram visualizing MURA cash flow for the period
Net decrease in
cash, cash...
-$18,481K
Right-of-use assets
-$1,227K
Depreciation
$797K
Other current assets
-$608K
Prepaid expenses
-$309K
Impairment on lab equipment
held-for-sale
$271K
Share-based compensation
expense
$109K
Other liabilities
$2K
Cash flows used in
operating activities
-$18,481K
Canceled cashflow
$3,323K
Accounts payable and
accrued expenses
-$16,472K
Net loss
-$3,706K
Operating lease
liabilities
-$1,626K
Buy us a coffee
Mural Oncology plc (MURA)
Mural Oncology plc (MURA)